ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Shattuck Labs Inc

Shattuck Labs Inc (STTK)

1.01
0.05
(5.55%)
1.01
0.00
( 0.00% )

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
1.01
Bid
0.9987
Ask
1.01
Volume
-
0.00 Day's Range 0.00
0.69215 52 Week Range 4.99
Market Cap
Previous Close
1.01
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
180,187
Shares Outstanding
47,899,240
Dividend Yield
-
PE Ratio
-0.64
Earnings Per Share (EPS)
-1.57
Revenue
5.72M
Net Profit
-75.41M

About Shattuck Labs Inc

Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restor... Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
-
Shattuck Labs Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker STTK. The last closing price for Shattuck Labs was $1.01. Over the last year, Shattuck Labs shares have traded in a share price range of $ 0.69215 to $ 4.99.

Shattuck Labs currently has 47,899,240 shares outstanding. The market capitalization of Shattuck Labs is $48.38 million. Shattuck Labs has a price to earnings ratio (PE ratio) of -0.64.

STTK Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.02512.54848207940.98491.030.906951010170.97681205CS
4-0.09-8.181818181821.11.2350.906951085091.06348815CS
120.0656.878306878310.9451.490.692151801871.07566272CS
26-0.08-7.339449541281.091.940.692151660871.19860172CS
52-3.34-76.78160919544.354.990.692153353352.07206643CS
156-3.05-75.12315270944.0611.760.692153251424.68374677CS
260-17.6-94.57281031718.6160.51620.692152835498.73005131CS

STTK - Frequently Asked Questions (FAQ)

What is the current Shattuck Labs share price?
The current share price of Shattuck Labs is $ 1.01
How many Shattuck Labs shares are in issue?
Shattuck Labs has 47,899,240 shares in issue
What is the market cap of Shattuck Labs?
The market capitalisation of Shattuck Labs is USD 48.38M
What is the 1 year trading range for Shattuck Labs share price?
Shattuck Labs has traded in the range of $ 0.69215 to $ 4.99 during the past year
What is the PE ratio of Shattuck Labs?
The price to earnings ratio of Shattuck Labs is -0.64
What is the cash to sales ratio of Shattuck Labs?
The cash to sales ratio of Shattuck Labs is 8.46
What is the reporting currency for Shattuck Labs?
Shattuck Labs reports financial results in USD
What is the latest annual turnover for Shattuck Labs?
The latest annual turnover of Shattuck Labs is USD 5.72M
What is the latest annual profit for Shattuck Labs?
The latest annual profit of Shattuck Labs is USD -75.41M
What is the registered address of Shattuck Labs?
The registered address for Shattuck Labs is 108 LAKELAND AVE, DOVER, DELAWARE, 19901
What is the Shattuck Labs website address?
The website address for Shattuck Labs is www.shattucklabs.com
Which industry sector does Shattuck Labs operate in?
Shattuck Labs operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
IBIOiBio Inc
$ 1.12
(57.22%)
10.73M
KZIAKazia Therapeutics Ltd
$ 10.00
(47.71%)
29
CBIOCrescent Biopharma Inc
$ 20.99
(37.19%)
168
NKTRNektar Therapeutics
$ 12.48
(30.82%)
203.14k
PSTVPlus Therapeutics Inc
$ 0.2409
(30.71%)
30.74M
UPXIUpexi Inc
$ 3.98
(-60.20%)
134.61k
MAASMaase Inc
$ 4.77
(-51.96%)
75.4k
HYFMHydrofarm Holdings Group Inc
$ 2.55
(-34.45%)
14
RBNERobin Energy Ltd
$ 4.88
(-27.16%)
304.57k
OPOceanPal Inc
$ 1.77
(-19.55%)
145.49k
ADILAdial Pharmaceuticals Inc
$ 0.3173
(20.65%)
39.03M
PSTVPlus Therapeutics Inc
$ 0.2409
(30.71%)
30.74M
IBIOiBio Inc
$ 1.12
(57.22%)
10.73M
GIBOGIBO Holdings Ltd
$ 0.7381
(30.41%)
9.8M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 15.01
(4.31%)
9.39M

STTK Discussion

View Posts
TrendTrade2016 TrendTrade2016 4 months ago
STTK HERE COMES 2.00
👍️0
TrendTrade2016 TrendTrade2016 4 months ago
STTK...2.40 MAGNET.....NO...DO WE DARE
👍️0
TrendTrade2016 TrendTrade2016 4 months ago
STTK...MINI MONSTER GETTING LOTS OF LOVE
👍️0
TrendTrade2016 TrendTrade2016 4 months ago
STTK...HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 4 months ago
STTK BUILDING MOMO
👍️0
PonkenPlonken PonkenPlonken 4 months ago
(STTK uses too) CD47
https://med.stanford.edu/news/all-news/2017/11/second-dont-eat-me-signal-found-on-cancer-cells.html

https://www.gilead.com/news/news-details/2020/gilead-to-acquire-forty-seven-for-49-billion
👍️0
TrendTrade2016 TrendTrade2016 4 months ago
HAVE NO CLUE WHAT THAT MEANS
👍️0
PonkenPlonken PonkenPlonken 4 months ago
I used to love this - always love me some dont eat me
👍️0
TrendTrade2016 TrendTrade2016 4 months ago
STTK LOW VOLUME MOVE....SO DILUTION OFF THE TABLE
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
STTK COMING OFF BOTTOM
👍️0
glenn1919 glenn1919 8 months ago
STTK............................https://stockcharts.com/h-sc/ui?s=STTK&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 10 months ago
STTK under $4
👍️0
PonkenPlonken PonkenPlonken 1 year ago
absolutely revolutionary data in HR MDS... compare to SOC!!! HMAs show a ORR 30%, CR 10-20%
(also beats venetoclax + HMA in TP53m AML)

Observed 79% Objective Response Rate (ORR) in frontline HR-MDS patients, primarily with TP53 mutations; initial complete response (CR)/marrow complete response (mCR) rate of 64% –

– Observed 27% initial CR/complete response with incomplete hematologic recovery (CRi) in frontline TP53m AML patients, and 5/11 evaluable patients achieved stable disease with decreasing blast counts and peripheral blood count improvement, these patients continue on treatment
👍️0
Monksdream Monksdream 1 year ago
STTK new 52 week high
👍️0
Monksdream Monksdream 1 year ago
STTK new 52 week high
👍️0
Monksdream Monksdream 1 year ago
STTK new 52 week low
👍️0
tbonaces80 tbonaces80 2 years ago
Takeda gonna tender on next trial fast track
👍️0
tbonaces80 tbonaces80 2 years ago
load it-going to 10+
👍️0
subslover subslover 2 years ago
No fooling? So you say a 1.75% profit for a two-hour trade is a bad trade?
👍️0
tbonaces80 tbonaces80 2 years ago
Bad trade
👍️0
subslover subslover 2 years ago
Ok. I got out of this POS this morning at $5.00, got lucky is all
👍️0
TheFinalCD TheFinalCD 2 years ago
@ 4.29 I was just looking for a move under $4 and it did

small gain, but I didnt know how many borrows I could get if it went against me

sometimes I go short, and get upside down and cant average up, because broker all of a sudden has NO available shares to short= your stuck

so thats why I dont short much
👍️0
subslover subslover 2 years ago
What price did you short?tia
👍️0
TheFinalCD TheFinalCD 2 years ago
I shorted it... Its just Phase 1

AI bot hyper extended the POP

I used to chase these Pase 1 rallys, lost lots of money doing so

some of my biggest losses ever

Phase 1 Gap & Traps
👍️0
subslover subslover 2 years ago
Did you see this open? $7.28! then immediately dropped down to $2.50 omg. I'm in at $3.00 just hoping for the best. Worth a shot
👍️0
TheFinalCD TheFinalCD 2 years ago
$STTK KEEP THIS ON WATCH! pic.twitter.com/6owPN2LcXn— Tiger Line Trading (@TigerLineTrades) December 13, 2023
👍️0
subslover subslover 2 years ago
$TSOI's new Introducing the ALScell™, also known as the JadiCell™ – Now, these ALScells are not your run-of-the-mill mesenchymal stem cells; they're basically the overachievers of the cellular world. These ALScells have it all – enhanced growth factor production, like they've been hitting the gym and drinking protein shakes on a regular basis. They can secrete exosomes , outshining their stem cell peers who are still trying to figure out how to tie their cellular shoelaces.

But wait, there's more! These ALScells are not just content with being academically gifted; they've got some serious street smarts too. Superior angiogenic and neurogenic abilities mean they're like the cool kids who not only excel in science class but also throw legendary parties in the cellular neighborhood.

And guess what? Exosomes are not just a fancy word; they're the VIP pass to the cure of many cancers. It's like the ALScells are hosting the party, and exosomes are the invitations that cancer cells can't resist.

So, say hello to the ALScell™ – the cellular superhero ready to save the day, one enhanced growth factor at a time, and unlocking cures like a boss!
Bullish
BULLISH
👍️0
Awl416 Awl416 2 years ago
Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Pati
👍️0
Monksdream Monksdream 2 years ago
STTK under $2
👍️0

Your Recent History

Delayed Upgrade Clock